BioWorld - Monday, December 15, 2025

Analysis and data insight
Analysis and data insight RSS Feed RSS

Med-tech financings September 2023

Med-tech companies raise $646M in September, down 44% through Q3

Oct. 9, 2023
By Amanda Lanier
Through the third quarter 2023 med-tech firms raised $14.35 billion in financings, down 43.82% from $25.55 billion raised in the same period last year. Money raised is also down from $42.04 billion raised in 2021, $47.61 billion in 2020 and $29.66 billion in the first nine months of 2019.
Read More
Digital stock chart
BioWorld Biopharmaceutical Index (BBI)

Biopharma stocks stay strong, end Q3 higher than NBI and Dow

Oct. 9, 2023
By Amanda Lanier
The BioWorld Biopharmaceutical Index (BBI) has fallen from its highest point this year to close September up 5.91% since the start of the year. BBI was down 3.65% at the end of February, peaked at 7.87% at the end of August, then closed up 5.91% on Sept. 29, tracking higher than both the Nasdaq Biotechnology Index (NBI) and Dow Jones Industrial Average.
Read More

Money raised by biopharma

Oct. 6, 2023
Total raised in public, private and other financings of biopharma companies, comparing 2023 vs. 2022 vs. 2021 vs. 2020 vs. 2019.
Read More
Global currency
Biopharma financings September 2023

Value of biopharma financings in September the highest in 2023

Oct. 6, 2023
By Amanda Lanier
Through September 2023, biopharmas raised a total of $49.15 billion, up 7.46% in value from the $45.74 billion raised in the same period last year. Value is down from $93.98 billion raised in 2021 and $104.09 billion in 2020, but up from $42.17 billion raised in 2019 in the same time period.
Read More